Drugmakers Find Much To Love In Final FDA Reform Bill

Law360, New York (June 19, 2012, 9:24 PM EDT) -- The U.S. House of Representatives is expected to vote Wednesday on a final version of the Food and Drug Administration user fee bill, which has been stripped of controversy but will still largely benefit the industry, with provisions extending exclusivity for certain drugs and directing the FDA to accept foreign clinical data and issue a comprehensive social media policy.

Three weeks of negotiations to reconcile the House and Senate versions of the bill stripped the legislation of controversy, including an industry-backed proposal to create a nationwide...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.